Peptide LL-37 is an endogenous cathelicidin with a broad spectrum of antimicrobial activity. It plays an important role in maintaining skin health by improving its barrier functions and accelerating the wound healing ...

Peptide LL-37 is an endogenous cathelicidin with a broad spectrum of antimicrobial activity. It plays an important role in maintaining skin health by improving its barrier functions and accelerating the wound healing process. Additionally, LL-37 has moderate anti-inflammatory properties, making it an effective agent for treating various skin diseases.

LL-37 — an endogenous cathelicidin (37 amino acids, hCAP-18 fragment), a powerful antimicrobial peptide of the immune system with a broad-spectrum effect on bacteria, viruses, fungi, and biofilms.

Properties and mechanism

LL-37 destroys microbial membranes (amphiphilic α-helix), neutralizes LPS (endotoxins), modulates immunity: neutrophil/monocyte chemotaxis, mast cell degranulation, angiogenesis, and wound healing.

It improves the skin barrier (hydration, epithelium regeneration), reduces inflammation (IL-6, TNF-α), stimulates blood vessel growth; dual role in oncology (apoptosis or proliferation).

Area

Effects

Infections

Chronic (staph/candida), sepsis, long COVID

Immunity

Leaky gut, autoimmunity (psoriasis ↓)

Regeneration

Wounds/burns x2-3, acne, colitis

Anti-age

Inflammation ↓, skin/gut

Trends 2026

Dermatology/immunity: Top 10 in post-procedural therapy (Refresh Clinic: LL-37 + BPC-157); combo with antibiotics against resistance; nanoforms for acne.

Improves the skin barrier (hydration, epithelium regeneration), reduces inflammation (IL-6, TNF-α), stimulates blood vessel growth; dual role in oncology (apoptosis or proliferation).

LL-37 — Innate Immunity N1 for Skin and Infections

The LL-37 peptide is an important component of the human immune system. Its antimicrobial properties and ability to regulate inflammation make it a promising candidate for the development of new medicinal drugs.

Stack

Effect

Dose LL-37 + partner

LL-37 + BPC-157

Wounds + infections x4

100+250 mcg

LL-37 + TB-500

Skin/ligaments

150+500 mcg

LL-37 + GHK-Cu

Regen + immunity

100 mcg + 1 mg

LL-37 + Vit D

LL-37 ↑500%

100 mcg + 5000 IU

The use of the LL-37 peptide is indicated for conditions such as acne and skin infections. It is also widely used in post-procedural rehabilitation, helping the skin recover faster after various cosmetic procedures. Due to its unique properties, LL-37 is a valuable component in the arsenal of dermatologists and cosmetologists, contributing to improved skin condition and enhanced protective functions.

Information

Information about peptides is provided for informational and reference purposes only. The peptides presented are for research and laboratory use only and are not intended for human or veterinary use or consumption. The information on this website does not constitute medical advice, a prescription, or instructions for use and is not intended for the diagnosis, treatment, or prevention of any disease. Peptides displayed in the catalogue are not offered for sale through this website. A consultation does not constitute a means of ordering, purchasing, or obtaining any products displayed. Images are for illustrative purposes only.